Stay updated on NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial
Sign up to get notified when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.

Latest updates to the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 is now displayed on the page. The government funding lapse notice and the earlier Revision: v3.4.1 text have been removed.SummaryDifference0.5%

- Check61 days agoChange DetectedSite-wide notice about a lapse in government funding and open status was added, and the page revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedA glossary toggle was added; labels such as 'Last Update Submitted that Met QC Criteria' were capitalized, capitalization adjusted for 'No FEAR Act Data', and the revision reference updated to v3.4.0 from v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedThe AMD topic and related MedlinePlus Genetics topics were removed from the page content. This reduces the page’s contextual references to AMD and associated resources.SummaryDifference0.2%

Stay in the know with updates to NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.